Cancer Program Archives - Page 2 of 6 - Harry Perkins Institute of Medical Research

About Us
About Perkins

Since 1998, the Perkins has grown to become one of the nation's leading adult medical research centres, where a close-knit team of more than 450 research and clinical staff work together to defeat the major diseases that impact our community.
Research
Research

Perkins researchers focus on some of the major diseases that affect our community. In particular we focus on cancer, diabetes, heart disease and neuromuscular diseases.
Support the Perkins
Support the Perkins

Your support will help us to deliver a healthier future through medical breakthroughs, new treatments and fostering the next generation of scientific talent.
Get Involved
Get Involved

You can support Perkins work in many different ways. From participating in an event, to attending a workshop in the BioDiscovery Centre, to volunteering your time, or supporting our research, we welcome your involvement.
Donate

Cancer News & Events Research xOncofetal Ecosystem

Researchers find link to anti-ageing element

By Richard Schoonraad | Cancer, News & Events, Research, xOncofetal Ecosystem

Researchers discover that increasing a naturally occurring chemical slows ageing process Ageing is inevitable as systemic changes occur in our bodies, but the question that puzzled researchers at the Harry…

Cancer Cancer Immunotherapy Liver Cancer Media Releases Melanoma Melanoma Discovery Melonoma News & Events Research Translation Tumours

WA melanoma research featured at global Oncology congress

By Richard Schoonraad | Cancer, Cancer, Immunotherapy, Liver Cancer, Media Releases, Melanoma, Melanoma Discovery, Melonoma, News & Events, Research, Translation, Tumours

Breakthrough research from the Harry Perkins Institute of Medical Research that explores possible new treatments for melanoma will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting.…

Bacteria Cardiovascular Science and Diabetes Program Emergency Medicine Kidney Disease Media Releases News & Events Synthetic Biology and Drug Discovery Targeted Drug Delivery Translation

Antibiotics resistance solution to be commercialised

By Richard Schoonraad | Bacteria, Cardiovascular Science and Diabetes Program, Emergency Medicine, Kidney Disease, Media Releases, News & Events, Synthetic Biology and Drug Discovery, Targeted Drug Delivery, Translation

Breakthrough diagnostic technology to be commercialised in Australia in race to save millions globally from antibiotic resistant sepsis. CUREator funds Western Australian research team to develop life-saving technology through the…

Bioimaging Research and Innovation for Translational Engingeering BRITE Funding Imaging and Therapy Media Releases News & Events

Perth MedTech firm secures funding for cannula innovation

By Richard Schoonraad | Bioimaging Research and Innovation for Translational Engingeering BRITE, Funding, Imaging and Therapy, Media Releases, News & Events

VeinTech awarded $493,489 of Accelerating Commercialisation funding Perth based medical device company VeinTech is excited to announce it has secured $493,489 of matched non-dilutive funding to continue its efforts to…

Bioimaging Research and Innovation for Translational Engingeering BRITE Cancer Cancer Cancer Epigenetics Cell Signalling Cell-To-Cell Communication Functional Genomics Genes Media Releases News & Events Single Cell

New liver cancer blood test gets $2.5m research funding boost

By Richard Schoonraad | Bioimaging Research and Innovation for Translational Engingeering BRITE, Cancer, Cancer, Cancer Epigenetics, Cell Signalling, Cell-To-Cell Communication, Functional Genomics, Genes, Media Releases, News & Events, Single Cell

Predicting relapse for one of the world's deadliest cancers. Perth cancer researchers are on track to improve the outcomes of patients with the most common type of primary liver cancer.…

ACRF Centre for Advanced Cancer Genomics opens in Perth

Latest technology analyses WA cancer patient tumours. The Australian Cancer Research Foundation (ACRF) Centre for Advanced Cancer Genomics, housing the next generation DNA sequencing technology, was opened today at the…

Bioimaging Research and Innovation for Translational Engingeering BRITE Brain Cancer Inspiration Melonoma News & Events

Reasons for hope this festive season

By Richard Schoonraad | Bioimaging Research and Innovation for Translational Engingeering BRITE, Brain, Cancer, Inspiration, Melonoma, News & Events

Prof Peter Leedman AO, Director of the Harry Perkins Institute of Medical Research, provided the following end-of-year observations about the outlook for medical research in WA to The West Australian,…

Bioimaging Research and Innovation for Translational Engingeering BRITE Biomedical engineering Breast Cancer Breast Cancer News & Events

First in-human use of Onco-Res Medical’s cancer imaging technology successful

By Richard Schoonraad | Bioimaging Research and Innovation for Translational Engingeering BRITE, Biomedical engineering, Breast Cancer, Breast Cancer, News & Events

Quantitative Micro-Elastography (QME) Imaging System published in peer reviewed Cancer Research OncoRes Medical today announced positive data from the first in-cavity use of its Quantitative Micro-Elastography (QME) Imaging System. The…

Bioimaging Research and Innovation for Translational Engingeering BRITE Biomedical engineering News & Events

Biodesign Australia brings global medical device innovation leaders to Perth

By Richard Schoonraad | Bioimaging Research and Innovation for Translational Engingeering BRITE, Biomedical engineering, News & Events

Biodesign Australia brought together 31 Biodesign leaders from around the world representing Biodesign programs from Stanford University, Texas Medical Center, Taiwan, Singapore, Japan, Israel, Melbourne, Sydney, Adelaide and Perth to…